Depot-medroxyprogesterone acetate injection (Depo-Provera®): a highly effective contraceptive option with proven long-term safety
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Contraception
- Vol. 68 (2) , 75-87
- https://doi.org/10.1016/s0010-7824(03)00136-7
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Myocardial infarction in users of low-dose oral contraceptivesPublished by Wolters Kluwer Health ,1999
- Low‐dose oral contraceptives and 24‐hour ambulatory blood pressureInternational Journal of Gynecology & Obstetrics, 1997
- A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptivesThe Journal of Pediatrics, 1996
- Protective effect of depot‐medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case‐control studyBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Stroke in Users of Low-Dose Oral ContraceptivesNew England Journal of Medicine, 1996
- Medroxyprogesterone acetate (Depo-Provera) use in adolescents: Uterine bleeding and blood pressure patterns, patient satisfaction, and continuation ratesAdolescent and Pediatric Gynecology, 1996
- Perceptions of Breast Cancer Risk and Screening Effectiveness in Women Younger Than 50 Years of AgeJNCI Journal of the National Cancer Institute, 1995
- Hormonal contraceptionInternational Journal of Gynecology & Obstetrics, 1995
- Uterine leiomyomataInternational Journal of Gynecology & Obstetrics, 1994
- Oral contraception noncompliance: The extent of the problemAdvances in Contraception, 1992